Key points
- Literature surveillance activities should operate under defined governance and oversight processes.
- Organisations should monitor screening activity, trends, and operational performance using defined metrics.
- Quality control checks should confirm that screening decisions and case identification are consistent.
- Oversight should include periodic review of literature monitoring activity and resolution of issues or deviations.
- Where literature monitoring is outsourced, organisations remain responsible for oversight and vendor performance monitoring.
- Inspection-ready evidence should demonstrate ongoing control of literature surveillance processes.
What inspectors expect
Each point below should be supported by controlled documents and traceable records.
- Literature surveillance processes operate under defined governance structures.
- Operational performance is monitored through defined metrics and periodic review.
- Quality control checks confirm screening accuracy and case identification consistency.
- Issues identified in literature monitoring processes are investigated and addressed.
- Vendor-performed monitoring activities are subject to defined oversight controls.
Summary
Inspectors assess whether literature surveillance operates under effective governance and oversight. They typically review oversight meeting records, operational metrics, quality control evidence, and documentation showing that issues identified in the literature monitoring process are investigated and resolved.
Common questions
These are the questions this page is designed to answer directly.
- What oversight do regulators expect for pharmacovigilance literature surveillance?
- How should literature surveillance activities be governed?
- What metrics should be monitored for literature screening?
- How do inspectors assess literature surveillance oversight?
- What documentation proves literature monitoring is controlled?
- How should vendor-performed literature monitoring be overseen?
- What KPIs should pharmacovigilance teams track for literature surveillance?
- What evidence demonstrates literature surveillance governance?
- What inspection findings occur for weak literature surveillance oversight?
- How often should literature monitoring performance be reviewed?
Evidence objects inspectors expect
Literature Surveillance Governance Framework
- Defined ownership of literature surveillance activities
- Responsibilities for operational execution and oversight
- Defined review cadence for surveillance performance
- Escalation pathways for deviations or issues
Literature Monitoring Metrics
- Number of literature searches performed
- Number of results screened
- Potential cases identified
- Timeliness of screening activities
- Trend analysis across reporting periods
Quality Control Evidence
- QC review of screening decisions
- Sampling of literature screening records
- Consistency checks between reviewers
- Evidence of corrective actions where discrepancies occur
Oversight Meeting Records
- Periodic literature surveillance review meetings
- Review of operational performance metrics
- Documentation of issues identified
- Action tracking and follow-up evidence
Vendor Oversight Documentation (Where Outsourced)
- Vendor qualification or selection records
- Defined KPIs and performance expectations
- Periodic vendor performance reviews
- Issue escalation and CAPA documentation
Regulatory Basis (Primary Sources)
- GVP Module VI – MAHs remain responsible for pharmacovigilance activities including literature monitoring
- ICH E2D – requirements for identification and reporting of literature cases
- EMA Medical Literature Monitoring guidance – expectations for screening, quality control, and reporting processes
- MHRA pharmacovigilance guidance – MAH responsibility for maintaining effective PV system oversight
Typical Inspection Questions (What Inspectors Ask)
- How do you oversee the literature surveillance process?
- What metrics do you monitor for literature screening performance?
- Show evidence of oversight reviews for literature monitoring.
- How are discrepancies in screening decisions identified and addressed?
- How do you oversee vendors performing literature monitoring?
Failure patterns
No defined oversight of literature surveillance activity beyond operational execution.
Operational metrics are not monitored or reviewed periodically.
Quality control checks for screening decisions are not performed or documented.
Issues identified during literature monitoring are not tracked or resolved.
Vendor-performed literature monitoring lacks documented oversight.
What good looks like
- Operational metrics are monitored and reviewed on a defined cadence.
- Quality control checks confirm screening consistency and case identification accuracy.
- Oversight meetings review trends, issues, and actions related to literature monitoring.
- Vendor monitoring performance is reviewed against defined KPIs where outsourced.
- Actions arising from oversight reviews are documented and tracked to closure.
Operationalisation
- Define governance ownership for literature surveillance activities.
- Track operational metrics such as screening volume, potential cases, and timeliness.
- Implement quality control sampling of literature screening decisions.
- Conduct periodic oversight reviews of literature surveillance activity.
- Document actions arising from oversight reviews and track them to closure.
- If literature monitoring is outsourced, define KPIs and perform periodic vendor oversight reviews.
Need regulatory documentation today?
Save time and reduce inspection risk with structured, pre-built process-ready documentation.
Created by industry professionals, adaptable to your organisation.
Related pre-built documentation inside the app
FAQ
Why is oversight required for literature surveillance?
Regulators expect literature monitoring to operate under controlled pharmacovigilance system governance. Oversight demonstrates that literature surveillance is consistently executed and monitored.
What metrics should be monitored for literature surveillance?
Organisations commonly track the number of searches performed, results screened, potential cases identified, screening timeliness, and trends across monitoring periods.
Do inspectors review literature surveillance oversight?
Yes. Inspectors often request evidence of oversight meetings, operational metrics, and quality control checks to confirm that literature surveillance processes are controlled.
Is vendor oversight required for outsourced literature monitoring?
Yes. Even when outsourced, the marketing authorisation holder remains responsible for ensuring literature surveillance is performed correctly and should demonstrate vendor oversight.
What evidence demonstrates effective literature surveillance oversight?
Evidence typically includes governance documentation, operational metrics, QC reviews, oversight meeting records, and documented actions arising from monitoring activities.
Sources
Primary guidance used to inform this map. This page is a structured interpretation layer; always validate against the original source documents.
European Medicines Agency (EMA)
- Good pharmacovigilance practices (GVP)View source
- Guideline on good pharmacovigilance practices (GVP) – Module VIView source
International Council for Harmonisation (ICH)
- Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting (E2D)View source